Trial · NCT02134314
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Patients Enrolled With Serum Creatinine >3mg/dL on Postoperative Day 5. | First 7 days post-transplant | Number of participants in the C1INH and placebo groups with serum creatinine \>3mg/dL on postoperative day 5 |
| Primary | Number of Patients Enrolled Who Require at Least One Session of Dialysis in the First 7 Days Post Transplant. | First 7 days post-transplant | The proportion of patients enrolled who require at least one session of dialysis in the first 7 days post transplant (excluding those who are dialyzed for hyperkalemia). |
| Primary | Number of Patients With Serum Creatinine Reduction Ratio of < 30% From 24 to 48 Hours Post-transplant. | First 7 days post-transplant | Number of patients in the C1INH and placebo groups with serum creatinine reduction of \< 30% from 24 to 48 hours post-transplant. |
| Primary | Number of Dialysis Sessions Per Patient in the First 7 Days Post Transplant. | First 7 days post-transplant | Mean quantity of dialysis sessions per patient in the first 7 days post transplant. |
| Secondary | Serum Creatinine | Up to 90 days post-transplant | Mean serum creatinine on day 90 in mg/dL |
| Secondary | Creatinine Clearance | Up to 90 days post-transplant | Creatinine clearance calculated based on serum creatinine, milliliters per minute. |
| Secondary | 24h Urine Output | 24 hours post-transplant | 24 hour urine output post-transplantation measured in milliliters |
| Secondary | Mean Number of Patients on Dialysis | 15 to 30 days post-transplantation | Mean number of patients on dialysis at 15 to 30 days post-transplant |
| Secondary | Number of Patients With Delayed Graft Function (DGF) (Categorized by DGF Scale) | First 7 days post-transplant | DGF Scale: Grade 1 - immediate urine production and no need for dialysis with creatinine reduction ratio (CRR) between time 0 of transplantation and day 7 post-transplantation \>70% Grade 2 - creatinine reduction ratio (CRR) between time 0 of transplantation and day 7 post-transplantation of \>70% with need for dialysis Grade 3 - creatinine reduction ratio (CRR) between time 0 of transplantation and day 7 post-transplantation \<70% with no need for dialysis Grade 4 - creatinine reduction ratio (CRR) between time 0 of transplantation and day 7 post-transplantation of \<70% with need for dialysis. |
| Other | Overall Incidence of Serious Adverse Events | Up to 9 months post-transplant | Overall incidence of serious adverse events in the C1INH and placebo groups, number of events. |
| Other | Patient Survival | Up to 90 days post-transplant | Patient survival at 90 days post-transplantation |
| Other | Rate of Acute Cellular Rejection (ACR) | Up to 90 days post-transplant | Number of acute cellular and antibody mediated rejection episodes by day 90. |
| Other | Graft Survival | Day 90 Post-transplant | Number of Participants with Graft Survival at 90 Days Post-Transplant |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02134314/registered